These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7936646)

  • 1. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors.
    Murty VV; Li RG; Houldsworth J; Bronson DL; Reuter VE; Bosl GJ; Chaganti RS
    Oncogene; 1994 Nov; 9(11):3227-31. PubMed ID: 7936646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the DCC tumor suppressor gene in testicular germ cell tumors: mutations and loss of expression.
    Strohmeyer D; Langenhof S; Ackermann R; Hartmann M; Strohmeyer T; Schmidt B
    J Urol; 1997 May; 157(5):1973-6. PubMed ID: 9112574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
    Mathew S; Murty VV; Bosl GJ; Chaganti RS
    Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCC genetic alterations and expression in endometrial carcinoma.
    Ronnett BM; Burks RT; Cho KR; Hedrick L
    Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity of tumor suppressor genes in testis cancer.
    Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D
    Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
    Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
    Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
    Zhang J; Ding F; Wang X
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.
    Höhne MW; Halatsch ME; Kahl GF; Weinel RJ
    Cancer Res; 1992 May; 52(9):2616-9. PubMed ID: 1314700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors.
    Murty VV; Reuter VE; Bosl GJ; Chaganti RS
    Oncogene; 1996 Jun; 12(12):2719-23. PubMed ID: 8700532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity involving DCC gene in human colorectal cancers is correlated with the metastatic potential].
    Gao S; Xu W; Wan Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):250-2. PubMed ID: 9387312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelotype analysis of esophageal squamous cell carcinoma.
    Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma.
    Kelker W; Van Dyke DL; Worsham MJ; Christopherson PL; James CD; Conlon MR; Carey TE
    Anticancer Res; 1996; 16(4C):2365-72. PubMed ID: 8816836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic loss and somatic differentiation in human male germ cell tumors.
    Murty VV; Bosl GJ; Houldsworth J; Meyers M; Mukherjee AB; Reuter V; Chaganti RS
    Oncogene; 1994 Aug; 9(8):2245-51. PubMed ID: 7518576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues.
    Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER
    Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.